Table 1.
Clinical course and laboratory findings.
| Clinical parameters (reference values) | Previous hospital | Our hospital | ||
|---|---|---|---|---|
| January 2013 | January 2013a | February 2013 | March 2013 | |
| ANA | 1 : 320 | (±) | (±) | (−) |
| Anti-ds DNA Ab | (−) | (−) | NT | NT |
| Anti-Sm Ab | (−) | (−) | NT | NT |
| IgG aCL (0–9 U/mL) | 1 (−) | 3 (−) | NT | NT |
| IgG anti-β2GPI (<3.5 U/mL) | <1.3 (−) | <1.3 (−) | NT | NT |
| LAC (dRVVT) (0–1.2) | 1.24 (+) | 1.17 (−) | 0.98 (−) | 0.99 (−) |
aCL: anticardiolipin antibodies; ANA: antinuclear antibodies; β2GPI: β2 glycoprotein I; dRVVT: dilute Russell viper venom time; LAC: lupus anticoagulant; (−): negative; NT: not tested.
aAdmission to our hospital.